These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 33894539)

  • 21. The clinical presentation of attention deficit-hyperactivity disorder (ADHD) in children with 22q11.2 deletion syndrome.
    Niarchou M; Martin J; Thapar A; Owen MJ; van den Bree MB
    Am J Med Genet B Neuropsychiatr Genet; 2015 Dec; 168(8):730-8. PubMed ID: 26400629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuropsychiatric expression and catatonia in 22q11.2 deletion syndrome: An overview and case series.
    Butcher NJ; Boot E; Lang AE; Andrade D; Vorstman J; McDonald-McGinn D; Bassett AS
    Am J Med Genet A; 2018 Oct; 176(10):2146-2159. PubMed ID: 29777584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The hippocampi of children with chromosome 22q11.2 deletion syndrome have localized anterior alterations that predict severity of anxiety.
    Scott JA; Goodrich-Hunsaker N; Kalish K; Lee A; Hunsaker MR; Schumann CM; Carmichael OT; Simon TJ
    J Psychiatry Neurosci; 2016 Apr; 41(3):203-13. PubMed ID: 26599134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Further evidence for high rates of schizophrenia in 22q11.2 deletion syndrome.
    Monks S; Niarchou M; Davies AR; Walters JT; Williams N; Owen MJ; van den Bree MB; Murphy KC
    Schizophr Res; 2014 Mar; 153(1-3):231-6. PubMed ID: 24534796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated Proinflammatory Markers in 22q11.2 Deletion Syndrome Are Associated With Psychosis and Cognitive Deficits.
    Mekori-Domachevsky E; Taler M; Shoenfeld Y; Gurevich M; Sonis P; Weisman O; Weizman A; Gothelf D
    J Clin Psychiatry; 2017; 78(9):e1219-e1225. PubMed ID: 29141125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prodromal symptoms in adolescents with 22q11.2 deletion syndrome and schizotypal personality disorder.
    Shapiro DI; Cubells JF; Ousley OY; Rockers K; Walker EF
    Schizophr Res; 2011 Jun; 129(1):20-8. PubMed ID: 21507614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Completing the puzzle: The search for pieces in the understanding of psychosis risk in 22q11.2 deletion syndrome.
    Hooper SR; Shashi V
    Schizophr Res; 2017 Oct; 188():33-34. PubMed ID: 28768602
    [No Abstract]   [Full Text] [Related]  

  • 28. Predominant negative symptoms in 22q11.2 deletion syndrome and their associations with cognitive functioning and functional outcome.
    Schneider M; Van der Linden M; Menghetti S; Glaser B; Debbané M; Eliez S
    J Psychiatr Res; 2014 Jan; 48(1):86-93. PubMed ID: 24189154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Working Memory Impairments in Chromosome 22q11.2 Deletion Syndrome: The Roles of Anxiety and Stress Physiology.
    Sanders AF; Hobbs DA; Stephenson DD; Laird RD; Beaton EA
    J Autism Dev Disord; 2017 Apr; 47(4):992-1005. PubMed ID: 28083777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Velopharyngeal Structural and Muscle Variations in Children With 22q11.2 Deletion Syndrome: An Unsedated MRI Study.
    Kollara L; Baylis AL; Kirschner RE; Bates DG; Smith M; Fang X; Perry JL
    Cleft Palate Craniofac J; 2019 Oct; 56(9):1139-1148. PubMed ID: 31117824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between early-onset Parkinson disease and 22q11.2 deletion syndrome: identification of a novel genetic form of Parkinson disease and its clinical implications.
    Butcher NJ; Kiehl TR; Hazrati LN; Chow EW; Rogaeva E; Lang AE; Bassett AS
    JAMA Neurol; 2013 Nov; 70(11):1359-66. PubMed ID: 24018986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognitive behavioral therapy in 22q11.2 microdeletion with psychotic symptoms: What do we learn from schizophrenia?
    Demily C; Franck N
    Eur J Med Genet; 2016 Nov; 59(11):596-603. PubMed ID: 27639442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A rare mosaic 22q11.2 microdeletion identified in a Chinese family with recurrent fetal conotruncal defects.
    Chen W; Li X; Sun L; Sheng W; Huang G
    Mol Genet Genomic Med; 2019 Aug; 7(8):e847. PubMed ID: 31297990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contribution of congenital heart disease to neuropsychiatric outcome in school-age children with 22q11.2 deletion syndrome.
    Yi JJ; Tang SX; McDonald-McGinn DM; Calkins ME; Whinna DA; Souders MC; Zackai EH; Goldmuntz E; Gaynor JW; Gur RC; Emanuel BS; Gur RE
    Am J Med Genet B Neuropsychiatr Genet; 2014 Mar; 165B(2):137-47. PubMed ID: 24265253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome.
    Schneider M; Debbané M; Bassett AS; Chow EW; Fung WL; van den Bree M; Owen M; Murphy KC; Niarchou M; Kates WR; Antshel KM; Fremont W; McDonald-McGinn DM; Gur RE; Zackai EH; Vorstman J; Duijff SN; Klaassen PW; Swillen A; Gothelf D; Green T; Weizman A; Van Amelsvoort T; Evers L; Boot E; Shashi V; Hooper SR; Bearden CE; Jalbrzikowski M; Armando M; Vicari S; Murphy DG; Ousley O; Campbell LE; Simon TJ; Eliez S;
    Am J Psychiatry; 2014 Jun; 171(6):627-39. PubMed ID: 24577245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neutrophils to lymphocytes ratio and psychosis in 22q11.2 deletion syndrome - Clinical and scientific implications.
    Mekori-Domachevsky E; Taler M; Weinberger R; Guri Y; Dar S; Shani S; Dekel I; Weizman A; Gothelf D
    Schizophr Res; 2021 May; 231():164-169. PubMed ID: 33866261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Magnitude and heterogeneity of brain structural abnormalities in 22q11.2 deletion syndrome: a meta-analysis.
    Rogdaki M; Gudbrandsen M; McCutcheon RA; Blackmore CE; Brugger S; Ecker C; Craig MC; Daly E; Murphy DGM; Howes O
    Mol Psychiatry; 2020 Aug; 25(8):1704-1717. PubMed ID: 31925327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subcortical Signatures of Hemizygosity and Psychosis in 22q11.2 Deletion Syndrome: Finding Common Ground in Rare Genetic Variation.
    Eisenberg DP; Gregory MD; Berman KF
    Am J Psychiatry; 2020 Jul; 177(7):564-566. PubMed ID: 32605438
    [No Abstract]   [Full Text] [Related]  

  • 39. Update on the 22q11.2 deletion syndrome and its relevance to schizophrenia.
    Van L; Boot E; Bassett AS
    Curr Opin Psychiatry; 2017 May; 30(3):191-196. PubMed ID: 28230630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biological effects of COMT haplotypes and psychosis risk in 22q11.2 deletion syndrome.
    Gothelf D; Law AJ; Frisch A; Chen J; Zarchi O; Michaelovsky E; Ren-Patterson R; Lipska BK; Carmel M; Kolachana B; Weizman A; Weinberger DR
    Biol Psychiatry; 2014 Mar; 75(5):406-13. PubMed ID: 23992923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.